跳至主要内容
临床试验/NCT02178982
NCT02178982已完成不适用

Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome

Southeast University, China1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2014年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
134
试验地点
1
主要终点
Number of medical staff who comply the protocol treatment

研究概览

简要总结

The Acute Respiratory Distress Syndrome (ARDS) is one of common clinical critically diseases. In the United States, the incidence of ARDS reaches 31%, which is one of the main causes of death in patients. There is no unified treatment process for ARDS currently and the treatment measures are not yet standardized, so the standardization of ARDS treatment processes is needed to reduce mortality in patients. Following the evidence-based medicine principles and six-step treatment standards of ARDS, this study uses the method of multi-center randomized controlled clinical trials to evaluate the standardized treatment process of ARDS, which provides the basis for the standardized treatment of ARDS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged ≥ 18 years
  • admitted to the ICU
  • according to the diagnostic criteria of ARDS Berlin definition,admit patients with severe ARDS

排除标准

  • age <18 years old
  • be expected to die within 24 hours
  • end-stage malignancies
  • be participating in other studies, which may affect the results of this study
  • DNI (do not intubation) and DNR (do not recovery) patients
  • family members do not agree to sign an informed consent

结局指标

主要结局

Number of medical staff who comply the protocol treatment

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Southeast University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianfeng Xie

Zhongda Hospital

Southeast University, China

研究点 (1)

Loading locations...

相似试验